QualityStocksNewsBreaks Archives - Page 901 of 1481

FridayOct 30, 2020 11:25 am

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) Announces Q3 2020 Results, Appointment of Interim CEO and Chief Govt Affairs Officer

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, on Thursday announced results for its third quarter ended September 30, 2020. Among the Q3 highlights, the company reported a 275% growth in net sells, a gross margin of 32% and cash, cash equivalents and short-term investments of $45.1 million. In addition, the company’s board of directors named Tom Smith as its interim CEO, effective October 27, 2020. Marc Thomas stepped down from the CEO role and has been appointed to the newly created position of chief government affairs officer. “We are very excited for Tom to assume the additional…

FridayOct 30, 2020 11:06 am

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in BioWorld Article

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in a recent BioWorld article titled, “CBC-funded Affamed merges with Everinsight, extends portfolio with Kissei PD candidate.” The publication discusses the merging of Affamed Therapeutics Ltd., an emerging biopharmaceutical company focused on opthamology markets in Greater China and funded by the large global venture capital firm, CBC Group, and EverInsight Therapeutics Inc., a biopharmaceutical company focused on central nervous system disorders and also funded by CBC Group. EverInsight and VistaGen entered into an exclusive development and commercialization…

FridayOct 30, 2020 10:35 am

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Secures $2.26M in First Tranche of Over-Subscribed Non-Brokered Private Placement

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, has closed an initial tranche of an over-subscribed non-brokered private placement as previously announced on October 16, 2020, (the "offering"). According to the update, the company issued 11,307,500 units, each at a price of $0.20, for gross proceeds of $2,261,500.00. Each unit consists of one common share in the capital of the company and one common share purchase warrant (the "warrants"). Each warrant entitles the holder to purchase one common share in the capital of the company at an exercise…

FridayOct 30, 2020 10:35 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces PharmHouse Commencement of SISP

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday announced that PharmHouse Inc., its 49%-owned joint venture, has received approval from the Ontario Superior Court of Justice to commence its Sale and Investor Solicitation Process ("SISP"). According to the update, the SISP is intended to solicit interest in, and opportunities for, a sale of or investment in all or part of PharmHouse's assets or business. This may include a restructuring, recapitalization or other form of reorganization. PharmHouse has engaged BMO Capital Markets ("BMO") to lead the SISP with oversight from Ernst and Young Inc.…

FridayOct 30, 2020 9:21 am

QualityStocksNewsBreaks – Sustainable Green Team Ltd. (SGTM) Announces Audit Completion, Preparation for Uplisting, Receipt of New Order from 7-Eleven Stores

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, announced completion of its two-year 2018 and 2019 audit to commence the form-10 process to become fully reporting and for future uplisting. In addition, SGTM announced that its wholly owned subsidiary Mulch Manufacturing Inc. will be supplying quality mulch products and services to 7-Eleven stores throughout the Midwest U.S. and western New York, slated to commence in 2021. According to the update, the contract was received a week after the company closed an annual mulch supply contract with the City of Vero…

ThursdayOct 29, 2020 3:37 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Addition of BettermentRS, a Leading CBD Distributor

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products, has added health and wellness, CBD-focused, direct-store delivery (DSD) distributor BettermentRS to its list of distributors. The move will enhance WTER’s convenience and grocery store CBD-sales growth. Based on recent research, sales of hemp-derived CBD products in the United States totaled $4.2 billion in 2019, which represents a 562% increase over the previous year. During the same period, sales of CBD products at c-stores and gas stores grew by more than 2,275%, topping out $122 million. The research also noted that…

ThursdayOct 29, 2020 2:16 pm

QualityStocksNewsBreaks – Cannabis Global Inc.’s (CBGL) Advanced CBD Infusion Technologies Featured in SmallCapVoice.com Interview

Cannabis Global (OTC: CBGL), a science-forward company developing CBD infusion technologies and products while investing in fast-growing segments of the cannabis industry, was featured in a new interview with SmallCapVoice.com, Inc. (“SCV”). Among other topics, CBGL CEO Arman Tabatabaei joined SCV’s Stuart Smith to discuss Cannabis Global’s HempYouCanFee(TM) product line, as well as a new partnership that provides international reach. Tabatabaei discusses several provisional patents Cannabis Global has on deck, three of which are at the forefront of its growth strategy. Describing Cannabis Global’s CBD coffee pods and other exciting innovative products, as well as its ability to create new…

ThursdayOct 29, 2020 1:56 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Secures $11.5M in Upsized Public Offering

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a Vancouver, Canada-based company focused on manufacturing pharmaceutical-grade cannabinoids via synthetic biology, has closed its previously announced upsized public offering of 17,692,307 units of the company, each at a price of $0.65, including 2,307,692 units issued pursuant to the full exercise of the over-allotment option. The company secured aggregate gross proceeds of approximately $11.5 million in the offering. Williow Biosciences expects to use net proceeds for the commercialization of cannabigerol (“CBG”) and other portfolio cannabinoids of the company, general and administrative expenses, working capital and general corporate purposes. To view the full press release,…

ThursdayOct 29, 2020 1:33 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Notes Upcoming Launch of Bidi Vapor’s Newest Smokeless Nicotine Product

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has announced the upcoming launch of the Bidi(TM) Nicotine Pouch. Kaival Brands has an exclusive partnership and distribution agreement with Bidi(TM) Vapor, the creator of the Bidi Pouch, which is designed to provide a premium smokeless nicotine experience. The pouch features a tobacco-free nicotine formulation packed into an easy-to-carry pouch. With the nicotine-pouch sector forecast to reach $3.35 billion by 2025, the potential for the new product looks to be significant. The Bidi Pouch is positioned to leverage…

ThursdayOct 29, 2020 1:16 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Conditional FDA Acceptance of Proprietary Name for Lead Drug Candidate

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has received conditional FDA acceptance of the proprietary name REQORSA(TM), its lead drug candidate for treatment of non-small cell lung cancer. The drug candidate was known previously by the laboratory designation GPX-001. The approval of the new name marks a critical branding milestone for the company. Genprex’s REQORSA (pronounced “re-KORE-suh”) immunogene therapy features the company’s exclusive ONCOPREX(TM) nanoparticle delivery system that delivers cancer-fighting genes. The name will be resubmitted to the FDA for final review and approval after all required clinical trials…

Site Search

Company Search

Category: QualityStocksNewsBreaks